Literature DB >> 26150542

Fetal Endothelial Remodeling in Late-Onset Gestational Hypertension.

Silvia Visentin1, Ambrogio Pietro Londero2, Beatrice Bellamio1, Grazia Giunta1, Chiara Cosma3, Diego Faggian3, Mario Plebani3, Erich Cosmi4.   

Abstract

BACKGROUND: Recent studies reveal that offspring of pregnancies complicated by hypertensive disorders may have an increased cardiovascular risk. Genetic and nongenetic factors seem to play an important role in premature arterial disease. Endothelium may be significant for long-term remodeling of the arterial wall. The aim of the study was to assess fetal endothelial and renal function in late-onset gestational hypertension.
MATERIALS AND METHODS: This was a case-controlled study. Singleton pregnancies affected by late-onset gestational hypertension (after 34 weeks' gestation) and controls were included. Ultrasound examinations (fetal biometry, fetal Doppler, fetal aorta intima media thickness (aIMT), fetal kidney volumes, maternal Doppler, presence of uterine arteries protodiastolic notching from anomaly scan) and clinical data were collected. A sample of amniotic fluid was taken at delivery.
RESULTS: Fifty patients with late-onset hypertension and 50 controls were included. At growth scan (weeks 29-32) we found in the study group significantly higher fetal aIMT, umbilical artery pulsatility index (PI), fetal aorta PI, and mean uterine arteries PI with persistent bilateral notch. In the case group microalbuminuria levels were significantly higher than controls (1.32±0.11 vs. 1.10±0.13g/l, P < 0.0001), and there was a negative correlation between renal fetal volume at growth scan and amniotic microalbuminuria (r: -0.95, 95% C -0.97 to -0.90, P < 0.0001).
CONCLUSIONS: Gestational hypertension should be considered as one of the adverse early risk factors that might predispose to impaired fetal cardiovascular development during intrauterine life; therefore, this study provides further evidence to better understand the origins of cardiovascular diseases. © American Journal of Hypertension, Ltd 2015. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; late onset hypertension; renal failure; vascular remodeling.

Mesh:

Substances:

Year:  2015        PMID: 26150542     DOI: 10.1093/ajh/hpv103

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Ouabain Protects Nephrogenesis in Rats Experiencing Intrauterine Growth Restriction and Partially Restores Renal Function in Adulthood.

Authors:  Liang Chen; Jing Yue; Shulin Zhou; Yali Hu; Juan Li
Journal:  Reprod Sci       Date:  2020-08-07       Impact factor: 3.060

2.  A possible new approach in the prediction of late gestational hypertension: The role of the fetal aortic intima-media thickness.

Authors:  Silvia Visentin; Ambrogio P Londero; Martina Camerin; Enrico Grisan; Erich Cosmi
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

3.  Risk of gestational hypertension-preeclampsia in women with preceding endometriosis: A nationwide population-based study.

Authors:  Mei-Lien Pan; Li-Ru Chen; Hsiao-Mei Tsao; Kuo-Hu Chen
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

4.  Prepregnancy Endocrine, Autoimmune Disorders and the Risks of Gestational Hypertension-Preeclampsia in Primiparas: A Nationwide Population-Based Study in Taiwan.

Authors:  Mei-Lien Pan; Li-Ru Chen; Hsiao-Mei Tsao; Kuo-Hu Chen
Journal:  Int J Environ Res Public Health       Date:  2020-05-22       Impact factor: 3.390

Review 5.  The Assessment of Maternal and Fetal Intima-Media Thickness in Perinatology.

Authors:  Daniel Boroń; Jakub Kornacki; Ewa Wender-Ozegowska
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

6.  Provoking factors for postpartum chronic hypertension in women with preceding gestational hypertension/preeclampsia: A longitudinal cohort study of 22,798 pregnancies.

Authors:  Kuo-Hu Chen; Li-Ru Chen
Journal:  Int J Med Sci       Date:  2020-02-10       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.